JINNA LISENBE: Open Payments
NPI 1245658335 · ROLLA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$398 in 20 payments from 14 companies in 2025. Trend: 2023 $177 · 2024 $302 · 2025 $398
Food & beverage: $398
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 3 | $49 |
| Merck Sharp & Dohme LLC | 2 | $39 |
| Genentech USA, Inc. | 2 | $38 |
| Janssen Biotech, Inc. | 2 | $38 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
| ABBVIE INC. | 1 | $34 |
| JAZZ PHARMACEUTICALS INC. | 1 | $32 |
| Caris MPI, Inc. | 1 | $28 |
| Pharmacosmos Therapeutics Inc. | 1 | $21 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $18 |
Products named: JAKAFI, KEYTRUDA, KISQALI, VENCLEXTA, ZEPZELCA, MI CANCER SEEK, CARVYKTI, Polivy.
Industry payments across MO — which companies pay providers there.
